Display options
Share it on
Full text links
Wiley Free PMC Article

Br J Clin Pharmacol. 1981 Oct;12(4):523-33. doi: 10.1111/j.1365-2125.1981.tb01261.x.

The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

British journal of clinical pharmacology

P R Bittencourt, P Wade, A T Smith, A Richens

PMID: 6794587 PMCID: PMC1401908 DOI: 10.1111/j.1365-2125.1981.tb01261.x
Free PMC Article

Abstract

1 Six healthy male volunteers received single oral doses of 10 mg diazepam, 20 mg temazepam, 15 mg flurazepam, 5 mg nitrazepam, 10 mg desmethyl-diazepam and placebo in a double-blind randomized fashion. 2 Peak velocity of saccadic eye movements, serum benzodiazepine concentration, and subjective ratings of wakefulness and co-ordination were measured at intervals up to 12 h after drug administration. 3 All active treatments produced a statistically significant decrease in peak saccadic velocity. The effect of temazepam and diazepam was generally more pronounced than that of flurazepam, nitrazepam and desmethyl-diazepam. 4 There were log-linear correlations between peak saccadic velocity and serum benzodiazepine concentration after ingestion of temazepam, diazepam and nitrazepam. 5 These results demonstrate a clear relationship between serum benzodiazepine concentration and its effect on a convenient measure of brainstem reticular formation function.

Cited by

References

  1. Neurosci Lett. 1979 Aug;13(3):285-93 - PubMed
  2. Br J Clin Pharmacol. 1979;8(1):7S-13S - PubMed
  3. Ann Neurol. 1980 Mar;7(3):277-80 - PubMed
  4. Br J Clin Pharmacol. 1980 Sep;10(3):189-209 - PubMed
  5. J Biomed Eng. 1981 Jan;3(1):39-43 - PubMed
  6. J Neurol Neurosurg Psychiatry. 1980 Dec;43(12):1119-24 - PubMed
  7. AMA Arch Neurol Psychiatry. 1959 Feb;81(2):154-72 - PubMed
  8. Clin Pharmacokinet. 1978 Sep-Oct;3(5):381-94 - PubMed
  9. Physiol Rev. 1967 Apr;47(2):117-77 - PubMed
  10. J Pharmacol Exp Ther. 1968 Oct;163(2):439-47 - PubMed
  11. Arch Psychiatr Nervenkr (1970). 1968;211(4):325-32 - PubMed
  12. Vision Res. 1969 Oct;9(10):1247-58 - PubMed
  13. Clin Pharmacol Ther. 1971 Jul-Aug;12(4):563-74 - PubMed
  14. Vision Res. 1971 Sep;11(9):921-8 - PubMed
  15. J Neurophysiol. 1972 Jul;35(4):445-61 - PubMed
  16. Psychopharmacologia. 1972;25(2):117-32 - PubMed
  17. Brain Res. 1973 Aug 30;58(2):313-30 - PubMed
  18. J Pharm Sci. 1973 Nov;62(11):1789-96 - PubMed
  19. J Neurophysiol. 1974 Mar;37(2):316-32 - PubMed
  20. J Chromatogr. 1974 Nov 6;99(0):461-83 - PubMed
  21. Clin Pharmacol Ther. 1975 Jan;17(1):1-14 - PubMed
  22. Neurology. 1975 Nov;25(11):1065-70 - PubMed
  23. Anal Chem. 1976 Jan;48(1):10-9 - PubMed
  24. Clin Pharmacol Ther. 1976 Aug;20(2):184-91 - PubMed
  25. Neurology. 1976 Aug;26(8):769-76 - PubMed
  26. Aviat Space Environ Med. 1976 Sep;47(9):991-2 - PubMed
  27. Clin Pharmacol Ther. 1977 Aug;22(2):228-33 - PubMed
  28. Electroencephalogr Clin Neurophysiol. 1977 Aug;43(2):270-1 - PubMed
  29. Clin Pharmacokinet. 1978 Jan-Feb;3(1):72-91 - PubMed
  30. Br J Clin Pharmacol. 1978 Jul;6(1):3-4 - PubMed
  31. Clin Pharmacol Ther. 1978 Sep;24(3):308-15 - PubMed
  32. Br J Clin Pharmacol. 1978 Oct;6(4):325-31 - PubMed
  33. Neurology. 1978 Nov;28(11):1099-1104 - PubMed
  34. Arch Gen Psychiatry. 1979 Jan;36(1):95-102 - PubMed
  35. N Engl J Med. 1979 Apr 5;300(14):803-8 - PubMed
  36. Br J Clin Pharmacol. 1979;7 Suppl 1:61S-67S - PubMed
  37. Br Med J. 1979 Apr 7;1(6168):917-9 - PubMed
  38. Br J Clin Pharmacol. 1979;8(1):37S-38S - PubMed
  39. Drugs. 1980 Mar;19(3):195-219 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources